标题
|
N-Trifluoroacetyl-8-(2-tert-butyl(dimethyl)silyl]oxy) Doxorubicin
|
|
IUPAC标准名
|
N-[(2S,3S,4S,6S)-6-{[(1S,3S)-3-{2-[(tert-butyldimethyl-λ4-sulfanyl)oxy]acetyl}-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]-2,2,2-trifluoroacetamide
|
|
IUPAC传统名
|
N-[(2S,3S,4S,6S)-6-{[(1S,3S)-3-{2-[(tert-butyldimethyl-λ4-sulfanyl)oxy]acetyl}-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]-2,2,2-trifluoroacetamide
|
|
别名
|
(1S,3S)-2,3,6-Trideoxy-3-(2,2,2-trifluoroacetamido)-3-ert-butyl(dimethyl)silylglycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-α-L-lyxo-hexopyranoside
|
N-Trifluoroacetyl-8-(2-tert-butyl(dimethyl)silyl]oxy)adriamycin
|
|